Crossmark

Efficacy and safety of calcitriol therapy for reduction of proteinuria in children with chronic kidney disease: an open-label randomized controlled trial

Crossref DOI link: https://doi.org/10.1007/s11255-025-04623-x

Published Online: 2025-06-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Meena, Jitendra

Thergaonkar, Ranjeet W.

Sinha, Aditi

Lakshmy, R.

Bagga, Arvind

Hari, Pankaj
Funding

Funding for this research was provided by:

Indian Council of Medical Research
License Information

Text and Data Mining valid from 2025-06-29

Version of Record valid from 2025-06-29
More Information

Article History

Received: 23 February 2025

Accepted: 15 June 2025

First Online: 29 June 2025

Declarations

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below